Symptomatic Dyspnea In Acute Decompensated Heart Failure Therapeutics
1. Natrecor patent expiration
Treatment: Method to induce natriuresis, diuresis and/or vasodilation
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5114923 | SCIOS LLC | Recombinant techniques for production of novel natriuretic and vasodilator peptides |
May, 2014
(11 years ago) | |
Drugs and Companies using NESIRITIDE ingredient
Market Authorisation Date: 10 August, 2001
Dosage: FOR SOLUTION
More Information on Dosage
NATRECOR family patents
